Valuation: Zai Lab Limited

Market Cap 205.27Cr 178.44Cr 166.09Cr 152.49Cr 287.97Cr 20TCr 292.43Cr 1.96TCr 768.38Cr 9.76TCr 770.92Cr 753.99Cr 33TCr P/E 2026 *
-8.14x
P/E 2027 * -9.72x
Enterprise Value 155.92Cr 135.54Cr 126.16Cr 115.83Cr 218.74Cr 15TCr 222.13Cr 1.49TCr 583.65Cr 7.41TCr 585.59Cr 572.72Cr 25TCr EV / Sales 2026 *
3.48x
EV / Sales 2027 * 2.83x
Free-Float
95.17%
Yield 2026 *
-
Yield 2027 * -
1 day+1.96%
1 week-6.02%
1 month-1.27%
3 months-11.86%
6 months+12.23%
Current year+6.85%
1 week 15.3
Extreme 15.3
16.3
1 month 15.3
Extreme 15.3
17.8
Current year 13.2
Extreme 13.2
21
1 year 13.2
Extreme 13.2
34
3 years 12.4
Extreme 12.4
38.2
5 years 12.4
Extreme 12.4
130
10 years 12.4
Extreme 12.4
162
Manager TitleAgeSince
Chief Executive Officer 61 01/04/2014
Director of Finance/CFO 58 07/07/2023
President 62 01/12/2022
Director TitleAgeSince
Chairman 61 01/04/2014
Director/Board Member 83 01/01/2017
Director/Board Member 75 01/01/2017
Change 5-day change 1-year change 3-year change Capi.($)
+1.96%-6.02% - - 205.38Cr
+3.29%+16.25%+39.81%+2.79% 7.62TCr
-2.75%+48.50%+48.50%+48.50% 4.78TCr
+2.72%-9.39%+17.04%+176.83% 4.89TCr
-3.81%+7.74%-54.57%-54.17% 4.14TCr
-2.40%+0.38%+58.55%-24.89% 3TCr
-2.82%+1.57%+59.59%+87.57% 2.42TCr
-5.35%+1.39%+85.45%-53.41% 2.18TCr
-1.59%-3.61%-11.53%+150.58% 1.92TCr
-0.42%+2.89%+74.55%+128.45% 1.71TCr
Average -1.49%+1.48%+35.27%+51.36% 3.63TCr
Weighted average by Cap. -1.47%+2.98%+30.74%+43.63%

Financials

2026 *2027 *
Net sales 45Cr 39Cr 36Cr 33Cr 63Cr 4.27TCr 64Cr 426.94Cr 167.56Cr 2.13TCr 168.12Cr 164.42Cr 7.13TCr 59Cr 52Cr 48Cr 44Cr 83Cr 5.68TCr 85Cr 567.1Cr 222.57Cr 2.83TCr 223.31Cr 218.4Cr 9.48TCr
Net income -24Cr -21Cr -20Cr -18Cr -34Cr -2.33TCr -35Cr -232.86Cr -91Cr -1.16TCr -92Cr -90Cr -3.89TCr -16Cr -14Cr -13Cr -12Cr -22Cr -1.52TCr -23Cr -151.51Cr -59Cr -754.95Cr -60Cr -58Cr -2.53TCr
Net Debt -49Cr -43Cr -40Cr -37Cr -69Cr -4.71TCr -70Cr -470.67Cr -184.72Cr -2.35TCr -185.34Cr -181.26Cr -7.86TCr -37Cr -32Cr -30Cr -28Cr -52Cr -3.55TCr -53Cr -354.21Cr -139.02Cr -1.76TCr -139.48Cr -136.41Cr -5.92TCr
Logo Zai Lab Limited
Zai Lab Ltd is a holding company primarily engaged in biopharmaceutical business. The Company is focused on discovering, developing, and commercializing products that address medical conditions with significant unmet needs in the areas of oncology, immunology, neuroscience, and infectious disease. The Company has a series of patented drug candidates from the discovery stage to the late clinical project, including ZEJULA, OPTUNE, QINLOCK, NUZYRA and VYVGART, and others. The Company conducts its businesses within domestic and overseas markets.
Employees
1,784
Date Price Change
31/26/31 €15.60 +1.96%
30/26/30 €15.30 -3.16%
29/26/29 €15.80 -1.25%
28/26/28 €16.00 -1.84%
27/26/27 €16.30 -1.81%
Trader
Investor
-
Global
-
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
12
Last Close Price
18.27USD
Average target price
33.30USD
Spread / Average Target
+82.28%

Quarterly revenue - Rate of surprise